Wednesday, July 8, 2015

Recent Increase in Heroin Usage in U.S.

Health officials, confronted with a shocking increase in heroin abuse, are developing a clearer picture of who is becoming addicted to this drug and why. The results may surprise you.
The biggest surge is among groups that have historically lower rates of heroin abuse: women and white (non-Hispanic) Americans. They tend to be 18-25 years old, with household incomes below $20,000. "In addition, persons using heroin are abusing multiple other substances, especially cocaine and opioid pain relievers," says a reportpublished Tuesday by the Centers for Disease Control and Prevention.
All told, more than half a million Americans used heroin in 2013, according to the report. That represents a nearly 150 percent increase since 2007.
Men still outnumber women, but that gap is narrowing. And 96 percent of heroin users said they'd used other drugs within the past year.
In 2013 alone, more than 8,200 Americans died of heroin overdoses. Most of them took that as a deadly combination with other drugs — most often cocaine. The death toll has skyrocketed in recent years. It's up from 1,800 in 2001, according to a reportfrom the National Institute on Drug Abuse.
"As a doctor who started my career taking care of patients with HIV and other complications from injection drugs, it's heartbreaking to see injection drug use making a comeback in the U.S.," says Dr. Tom Frieden, head of the CDC. He unveiled the report in a phone briefing.
Those stark facts define the challenge that health officials face. The epidemic isn't just a problem of inner city "shooting galleries" and a dead end for the down-and-out. To a considerable extent, Frieden says the heroin "crisis" is growing out of prescription drug abuse, especially opioid painkiller use. People who abuse painkillers are 40 times more likely to abuse or be dependent on heroin, the study finds.
"It's really a one-two punch," Frieden said.
First, he says, the widespread use of opiate painkillers has primed people for heroin addiction. These drugs and heroin have essentially the same active ingredient. The second punch is that heroin is increasingly available, and often far cheaper than prescription painkillers. Frieden estimates that heroin is available on the street at one-fifth the cost of prescription pain pills.
This problem calls for a comprehensive response — one that recognizes the changing demographics of heroin use, says the CDC report, which is co-authored by Christopher Jones at the Food and Drug Administration along with colleagues from the CDC.
Frieden said "an urgent all-society response" is needed. It would include:
  • Tracking the use of prescription painkillers and making sure doctors only prescribe them as necessary.
  • Providing treatment to individuals who are addicted to these drugs.
  • Cracking down on smuggling and street sales of heroin, to drive up the price and discourage abuse.
  • Increasing the use of naloxone, a drug that can be injected into someone with a heroin overdose to reduce the risk of death.
For the full article, please visit National Public Radio's website at the link below:

Friday, June 26, 2015

NEWS: Huge Breakthrough!

STUDENTS CREATE CONCEPTUAL CONDOM THAT CHANGES COLORS TO INDICATE STD EXPOSURE



For the Full Story, Check out the article on ABC 7's website by clicking the link below:

Teenage students are pitching a conceptual invention to help curb the spread of STDs: a condom that changes colors when exposed to sexually transmitted diseases and infections.

Students Daanyaal Ali, 14, Muaz Nawaz, 13, and Chirag Shah, 14 of England's Isaac Newton Academy created a "smart condom" concept they're calling S.T. EYE, according to The Washington Post. The students delivered their research project to U.K.'s TeenTech Awards which aims to "help young teenagers see the wide range of career possibilities in Science, Engineering and Technology (STEM).

The conceptual prophylactic would be coated in antibodies that would interact with the antigens of an STD, causing the luminescent hue to change colors. The students said they believe the condom would be able to help identify exposure to chlamydia, herpes, HPV and syphilis all with different colors.

"We knew that STIs were a huge problem in the U.K.," Daanyaal told The Washington Post. "We saw a gap in the market and we wanted to help people feel safer."

The three young boys won top honors at the TeenTech Awards, winning a cash prize equivalent to around $1,500 and a trip to meet Prince Andrew at Buckingham Palace.

TeenTech chief executive Maggie Philbin said that the S.T. EYE is merely a concept right now, though some condom manufacturers have already approached the students about their research.

"We know most of these ideas remain ideas," Philbin told The Washington Post. "But some of them do make it."

Monday, May 18, 2015

HIV Vaccine Awareness Day

National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) is the lead for this day. Read and share this 2013 NIAID Bulletin about HIV Vaccine Awareness Day

http://www.niaid.nih.gov/news/newsreleases/2013/Pages/HVAD2013.aspx

The implementation of scientifically proven HIV prevention strategies is helping to reduce the number of new infections—the annual HIV infection rate globally fell by 22 percent from 2001 to 2011—but a great deal more must be done. Significant scale-up of proven HIV prevention strategies coupled with the discovery of new HIV treatment and prevention interventions are needed to achieve an end to the global HIV/AIDS pandemic. A safe, effective and durable HIV vaccine is an essential cornerstone to the long-term strategy to achieve this goal.
Developing a safe and effective HIV vaccine has been a long and difficult process largely because HIV has proven to be an especially tough target. Recent developments with the HVTN 505 clinical trial and analyses from the HVTN 503 “Phambili” vaccine study have been disappointing, but they also provided clear answers about investigational vaccine strategies that, ultimately, were not effective. Still, the new directions for HIV vaccines that have been recently initiated define our future path and will be pursued.
Among many projects, scientists continue to explore findings from the ArchiveRV 144 HIV vaccine study in Thailand, which, in 2009, provided proof-of-concept that an HIV vaccine can afford a modest level of protection. Ongoing research related to the Thai trial is providing important information about human immune responses and other factors that may explain why the investigational vaccine protected some trial volunteers from HIV infection but not others. Such data will help advance researchers’ understanding of HIV’s structure and vulnerabilities and help guide the development of future HIV vaccine candidates. Large-scale investigational vaccine clinical trials designed to build on the RV 144 results and create a more robust and durable level of protection are expected to begin in two-to-three years in South Africa.
In basic research, scientists are making important discoveries about broadly neutralizing antibodies capable of disabling a wide range of HIV strains when tested in the laboratory setting. For example, NIAID scientists recently charted the co-evolution of HIV and a strong antibody response in an HIV-infected study participant, who is one of the 20 percent of HIV-infected individuals who naturally develops broadly neutralizing antibodies to the virus after several years of infection. Their findings could help identify which proteins to use in an investigational vaccine to induce broadly neutralizing antibodies more quickly. In another advance, a team of NIH scientists recently developed a new tool to identify broadly neutralizing antibodies from blood samples, which could help speed HIV vaccine research.
Other interesting basic research findings have included the identification of a new HIV-suppressing protein, called CXCL4, in the blood of HIV-infected individuals. NIAID scientists found that CXCL4 binds to HIV in such a way that the virus cannot attach or enter a human cell, leading to the conclusion that it may serve to regulate viral replication in an infected individual and, therefore, control the pace at which HIV disease progresses. Additionally, NIAID researchers found that even though HIV diversifies widely in infected individuals over time, the virus strains that are passed on through heterosexual transmission often resemble the strain that originally infected the transmitting partner. Learning more about the characteristics of these dominant strains could help inform HIV vaccine design.

Recent NIAID investments in basic research toward innovative HIV vaccine discovery research and vaccine immunology and immunogen discovery should also prove fruitful in the coming years for HIV vaccine research.

On this HIV Vaccine Awareness Day, NIAID thanks the thousands of men and women who have selflessly volunteered for clinical studies and the scientists and clinicians working to find an effective HIV vaccine. NIAID shares your commitment and will continue the important research needed to make a protective HIV vaccine a reality.

NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

Tuesday, April 7, 2015

Get Yourself Tested

Here is a piece from the "GYT (Get Yourself Tested) FAQs" page. For more questions about STD's and STD Related topics visit the link below:

Why should I get tested?

Sexually transmitted diseases (STDs, also called sexually transmitted infections or STIs) are very common. Every year there are more than 20 million new cases of STDs in the U.S. By age 25, roughly one in two sexually active people will get one. If you think it can’t happen to you…think again. Since STDs often show no symptoms, many of those infected don’t even know it. The only way to know if you or a partner has an STD is to get tested. Here’s the good news: the side effects and health outcomes of most STDs can be treated, and many are curable. Putting off getting care for an STD can have lasting health effects for both women and men. Left untreated, some STDs can cause infertility (that is, make you unable to have children). Some can also increase your risk of getting cancer. And get this-already having an STD increases your risk of getting HIV and other STDs if you have sex with an infected partner.

If you notice any changes or irritations “down there,” or any unusual discharge or discomfort when urinating, you should see a health care provider immediately as these may be signs of an STD. However, not all genital infections are STDs. STDs can often be mistaken for common infections or irritations. For example, bumps like pimples or hair follicles on or around the genitals may be confused for genital warts. Women often confuse STDs with yeast infections and other conditions. That’s why it’s important to see a health care provider, who can determine what (if any) STDs you should be tested for.
Not everyone likes to talk about their sexual history. But, before you start a new sexual relationship, it’s a good idea to talk with your partner about your sexual history and getting tested for STDs. After all, you are not just having sex with your partner but with everyone they’ve had sex with…and everyone they’ve had sex with…and well, you get the point. It can be intimidating to think about, but taking charge and getting tested will help you take control over the situation.

Tuesday, March 31, 2015

April is STD Awareness Month

APRIL IS STD AWARENESS MONTH

Check out the CDC website link for more information on STD Awareness Month and more ideas for your outreach program


Know the facts! GYT: Get Yourself Tested
False assumptions about sexually transmitted diseases (STDs)—how they're spread, treated, and prevented—are everywhere and it can be especially hard for people to get the facts. Here are five you need to know:
  • You can't tell someone has an STD just by looking at them.
  • STD tests aren't always a part of a regular doctor visit.
  • Almost all STDs that can be spread via unprotected vaginal sex can also be spread through unprotected oral and anal sex.
  • Using a condom can take a lot of the worry out of sex, since it can prevent unintended pregnancy and protect you from STDs.
  • STD testing is a basic part of staying healthy.
Because half of the estimated 20 million STDs that occur in the United States each year are among young people, STD Awareness Month 2015 is focused on this population. This month-long observance provides an opportunity to clear up misperceptions about STD prevention and testing, and confront the unique challenges that young people face when it comes to preventing these infections.


Half of all sexually active young people in the United States will get an STD by the time they're 25—and most won't know it.
Know the Facts

Not having sex is the only way to prevent STDs. This includes vaginal, anal, and oral sex. If you are sexually active, however, you can lower your risk of getting STDs by:
  • Being in a long-term mutually monogamous relationship with a partner who has been tested and does not have STDs.
  • Limiting the number of people you have sex with if you have more than one partner.
  • Using latex condoms and dental dams the right way every time you have sex.
  • Getting an HPV vaccine, which can protect you against diseases (including cancers) caused by the human papillomavirus.

GYT: Get Yourself Tested

Getting yourself tested for STDs is one of the most important things you can do to protect your health. Not only is it quick and simple, it's also usually confidential. A 2014 study found that one-third of adolescents didn't talk about sexual health issues with their physicians at all during annual health visits. It is important to be honest with your health care provider about your sexual history so that he or she can provide you with the appropriate STD testing and prevention guidance. If you're not comfortable talking with your regular health care provider about STDs, there are many clinics that provide confidential and free or low-cost testing. It is also important that you find and visit a doctor or other medical provider who stays current on STD and HIV testing recommendations.

Share the Knowledge

Now that you know the facts, it's time to spread the word! The GYT: Get Yourself Tested campaign is a youth-oriented, empowering social movement to encourage young people to get tested and treated for STDs and HIV. GYT campaign materials have been developed for doctors, health departments, school administrators, and community-based organizations to help young people increase their knowledge about STD prevention and testing. You can order newly designed GYT posters, stickers, and postcards at CDC-INFO on Demand to display in schools, clinics, community organizations, and health departments.
GYT is a partnership between the American College Health Association, Kaiser Family Foundation, National Coalition of STD Directors, MTV, and Planned Parenthood Federation of America. Technical consultation for GYT is provided by the U.S. Centers for Disease Control and Prevention.

Wednesday, March 25, 2015

10 Reasons to Carry Condoms

10 Reasons to Carry Condoms, Always

10 Reasons to Carry Condoms, Always
As the co-founder of Sustain, people always ask me: “So like, do you just carry a ton of condoms around all the time?”
The answer is YES. I carry condoms around with me just like I carry lipstick, credit cards and tampons, but not just because I started a condom company.
Here are the ten reason every woman should carry condoms always:
  1. 1 in 4 Americans will contract an STD.
  2. Among unmarried women in their 20s, 70% of pregnancies are unintended.
  3. Only 21% of sexually active single women use condoms regularly.
  4. 1 in 4 college freshmen will contract an STD by the end of their first year of college.
  5. 16 – 24 year olds account for over half of all newly diagnosed STDs.
  6. People in their early 20s have the highest reported cases of syphilis and HIV.
  7. In the US there are 20 million new cases of STDs reported annually (that’s over 54,000 cases per day)!
  8. “I’m so upset we used a condom last night.” -said no one ever
  9. Condoms are no longer evidence of prostitution (Yes, this was recently very real.)
  10. The U.S. has the highest rates of STDs in the industrialized world.
As young, smart, successful men and women, we are failing ourselves by leaving our sexual health in someone else’s hands. As women, we especially need to overcome the ridiculous and dated stigma attached to buying and carrying condoms, and get on top of our sexual health. -Meika Hollender, Co-Founder, Sustain Condoms
For more awesome articles on Safe Sex, please visit the SUSTAIN CONDOMS webpage: sustaincondoms.com